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CORRECTION Open Access
Correction to: Toward a comprehensive
view of cancer immune responsiveness: a
synopsis from the SITC workshop
Davide Bedognetti1†, Michele Ceccarelli2, Lorenzo Galluzzi3,4,5, Rongze Lu2†, Karolina Palucka6, Josue Samayoa2†,
Stefani Spranger7†, Sarah Warren8†, Kwok-Kin Wong9, Elad Ziv10, Diego Chowell11, Lisa M. Coussens12,
Daniel D. De Carvalho13, David G. DeNardo14, Jérôme Galon15, Howard L. Kaufman16, Tomas Kirchhoff17,
Michael T. Lotze18, Jason J. Luke19, Andy J. Minn20, Katerina Politi21, Leonard D. Shultz22, Richard Simon23,
Vésteinn Thórsson24, Joanne B. Weidhaas25, Maria Libera Ascierto26, Paolo Antonio Ascierto27, James M. Barnes2,
Valentin Barsan28, Praveen K. Bommareddy29, Adrian Bot30, Sarah E. Church8, Gennaro Ciliberto31,
Andrea De Maria32, Dobrin Draganov33, Winson S. Ho34, Heather M. McGee35, Anne Monette36,
Joseph F. Murphy37, Paola Nisticò31, Wungki Park11, Maulik Patel2, Michael Quigley38, Laszlo Radvanyi39,
Harry Raftopoulos40, Nils-Petter Rudqvist3, Alexandra Snyder41, Randy F. Sweis19, Sara Valpione42,
Roberta Zappasodi47,48, Lisa H. Butterfield43, Mary L. Disis44, Bernard A. Fox45, Alessandra Cesano8,
Francesco M. Marincola46* and Society for Immunotherapy of Cancer (SITC) Cancer Immune Responsiveness Task
Force and Working Groups
Correction to: J Immuno Ther Cancer
https://doi.org/10.1186/s40425-019-0602-4
Following publication of the original article [1], the au-
thor reported that an author name, Roberta Zappasodi,
was missed in the authorship list.
The correction has been implemented in the original
article as well.
The publisher apologized for any inconvenience this
might has caused.
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